ArticleJournal of clinical medicine2022
Clinical Time Delay Distributions of COVID-19 in 2020-2022 in the Republic of Korea: Inferences from a Nationwide Database Analysis.
Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Impacts of relaxed mask policies on COVID-19 epidemics: a modeling study in South Korea.BMC infectious diseases · 2026Article
- Smallpox outbreak scenarios and reactive intervention protocols: A mathematical model-based analysis applied to the Republic of Korea.PloS one · 2026Article
- Quantitative analysis of self-reporting and contact tracing in heterogeneous risk groups: a stochastic modeling study of the COVID-19 outbreak in Daegu, Korea.BMC public health · 2025Article
- Wastewater-Based Surveillance of SARS-CoV-2 and Modeling of COVID-19 Infection Trends.Tropical medicine and infectious disease · 2025Article
- Optimal algorithms for controlling infectious diseases in real time using noisy infection data.PLoS computational biology · 2025Article
- Article
- The time between symptom onset and various clinical outcomes: a statistical analysis of MERS-CoV patients in Saudi Arabia.Royal Society open science · 2024Article
- Overcoming bias in estimating epidemiological parameters with realistic history-dependent disease spread dynamics.Nature communications · 2024Article
- Variability in the serial interval of COVID-19 in South Korea: a comprehensive analysis of age and regional influences.Frontiers in public health · 2024Article
- The impact of earlier reopening to travel in the Western Pacific on SARS-CoV-2 transmission.IJID regions · 2023Article
- Empirical distributions of time intervals between COVID-19 cases and more severe outcomes in Scotland.PloS one · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Epidemiological distributions of the coronavirus disease 2019 (COVID-19), including the intervals from symptom onset to diagnosis, reporting, or death, are important for developing effective disease-control strategies. COVID-19 case data (from 19 January 2020 to 10 January 2022) from a national database maintained by the Korea Disease Control and Prevention Agency and the Central Disease Control Headquarters were analyzed. A joint Bayesian subnational model with partial pooling was used and yielded probability distribution models of key epidemiological distributions in Korea. Serial intervals from before and during the Delta variant's predominance were estimated. Although the mean symptom-onset-to-report interval was 3.2 days at the national level, it varied across different regions (2.9-4.0 days). Gamma distribution showed the best fit for the onset-to-death interval (with heterogeneity in age, sex, and comorbidities) and the reporting-to-death interval. Log-normal distribution was optimal for ascertaining the onset-to-diagnosis and onset-to-report intervals. Serial interval (days) was shorter before the Delta variant-induced outbreaks than during the Delta variant's predominance (4.4 vs. 5.2 days), indicating the higher transmission potential of the Delta variant. The identified heterogeneity in region-, age-, sex-, and period-based distributions of the transmission dynamics of COVID-19 will facilitate the development of effective interventions and disease-control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.